TRAVERE THERAPEUTICS, INC. Available-for-sale Securities
TRAVERE THERAPEUTICS, INC. (TVTX) had Available-for-sale Securities of $202.94 million as of 2018-03-31, per its 10-Q filed 2018-07-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-07-06
- 2018-03-31: Available-for-sale Securities $202.94M.
- 2017-12-31: Available-for-sale Securities $201.24M.
- 2017-09-30: Available-for-sale Securities $204.88M.
- 2017-06-30: Available-for-sale Securities $206.72M.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2018-03-31 | $202.94M 10-Q · filed 2018-07-06 | |
| 2017-12-31 | $201.24M 10-K · filed 2018-07-06 | |
| 2017-09-30 | $204.88M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $206.72M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $206.29M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $214.87M 10-K · filed 2018-07-06 | |
| 2016-09-30 | $250.41M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $200.36M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $199.08M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $191.80M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $94.68M 10-Q · filed 2015-11-06 | |
| 2014-12-31 | $9.56M 10-K · filed 2016-02-26 | $9.56M 10-K · filed 2015-03-11 |
| 2014-06-30 | $3.56M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $1.35M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $132.99K 10-K/A · filed 2015-07-09 | |
| 2013-09-30 | $2.96M 10-Q/A · filed 2015-07-09 | |
| 2012-12-31 | $0.00 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |